The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine

Akira Komoriya(OncoImmune (United States)), Martin J. Humphries(Wellcome Centre for Cell-Matrix Research), Miljenko Mervič(United States Food and Drug Administration), S S Yamada(United States Food and Drug Administration), Leonard Green(United States Food and Drug Administration), Kenneth M. Yamada(National Institute of Dental and Craniofacial Research)
Journal of Biological Chemistry
August 1, 1991
Cited by 363


Related Papers